The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.

[1]  F. Kratz,et al.  Spectral characterization of ruthenium (III) transferrin. , 1993, Journal of inorganic biochemistry.

[2]  R. Crichton,et al.  Iron metabolism--new perspectives in view. , 1992, Biochemistry.

[3]  E. Baker,et al.  New perspectives on the structure and function of transferrins. , 1992, Journal of inorganic biochemistry.

[4]  D. Neville,et al.  Uptake and concentration of bioactive macromolecules by K562 cells via the transferrin cycle utilizing an acid-labile transferrin conjugate. , 1991, The Journal of biological chemistry.

[5]  M. Cazzola,et al.  Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects. , 1990, Blood.

[6]  Edward N. Baker,et al.  Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins , 1990, Nature.

[7]  S. Pizzo,et al.  Selectivity and stereospecificity of the reactions of dichlorodiammineplatinum(II) with three purified plasma proteins. , 1988, Journal of inorganic biochemistry.

[8]  H. Schugar,et al.  Detailed correlations between the ligand-to-metal charge-transfer (LMCT) spectra of copper(II) and ruthenium(III) imidazoles and imidazolates. Electronic structures of carbon-bound ruthenium(III) imidazoles and imidazolates , 1984 .

[9]  W Wolf,et al.  Preparation and metabolism of a cisplatin/serum protein complex. , 1980, Chemico-biological interactions.

[10]  M. Schlabach,et al.  The nonspecific binding of Fe3+ to transferrin in the absence of synergistic anions. , 1975, The Journal of biological chemistry.

[11]  P. Manoharan,et al.  Optical and magnetic properties and geometry of some d5 ruthenium complexes , 1973 .

[12]  M. Henn,et al.  New Ruthenium Complexes for the Treatment of Cancer , 1989 .

[13]  K. Takahashi,et al.  Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin. , 1985, Japanese journal of cancer research : Gann.